Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05873205
What this trial is testing

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Blood CancerRefractory Immune Cytopenias
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT03940586
What this trial is testing

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Who this might be right for
Cytomegalovirus (CMV) Infection
Merck Sharp & Dohme LLC 65
Testing effectiveness (Phase 2)Looking for participantsNCT07072494
What this trial is testing

CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study

Who this might be right for
Acute Lymphoblastic Leukemia
Zhujiang Hospital 30
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Large-scale testing (Phase 3)Study completedNCT00775931
What this trial is testing

Allogeneic Transplantation For Severe Osteopetrosis

Who this might be right for
Severe Osteopetrosis
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Study completedNCT00539695
What this trial is testing

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

Who this might be right for
Acute Lymphoblastic LeukemiaALLAcute Myelogenous Leukemia+7 more
Baylor College of Medicine 25
Testing effectiveness (Phase 2)Looking for participantsNCT07362095
What this trial is testing

Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)

Who this might be right for
Acute Leukemia
Zhujiang Hospital 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457
What this trial is testing

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin
Assistance Publique - Hôpitaux de Paris 84
Early research (Phase 1)Looking for participantsNCT06809712
What this trial is testing

Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Disease
He Huang 29
Testing effectiveness (Phase 2)WithdrawnNCT02577094
What this trial is testing

Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia

Who this might be right for
Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia
Nantes University Hospital
Testing effectiveness (Phase 2)Study completedNCT00054353
What this trial is testing

Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
Fred Hutchinson Cancer Center 16
Not applicableStudy completedNCT03889028
What this trial is testing

Pre-engraftment Cytomegalovirus DNAemia

Who this might be right for
CMV DNAemia Pre-engraftment
Fundación para la Investigación del Hospital Clínico de Valencia 878
Testing effectiveness (Phase 2)UnknownNCT02848105
What this trial is testing

Valproic Acid With Methylprenisonlone for the Treatment of Acute GVHD

Who this might be right for
Peripheral Blood Stem Cell TransplantationaGVHD
Shanghai Jiao Tong University School of Medicine 55
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Not applicableLooking for participantsNCT03357172
What this trial is testing

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Central Hospital, Nancy, France 700
Early research (Phase 1)Ended earlyNCT04614636
What this trial is testing

FT538 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAML, AdultMultiple Myeloma+1 more
Fate Therapeutics 42
Testing effectiveness (Phase 2)UnknownNCT04897139
What this trial is testing

Flu-Bu-Mel Based Conditioning Regimen for Patients With Lymphoid Malignancies Undergoing Allo-HSCT

Who this might be right for
Lymphoid Neoplasm
Shanghai Jiao Tong University School of Medicine 23
Early research (Phase 1)Active Not RecruitingNCT04623944
What this trial is testing

NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS

Who this might be right for
Relapsed/Refractory AMLAML, AdultMDS+1 more
Nkarta, Inc. 61
Next Page